<?xml version="1.0" encoding="UTF-8" standalone="no"?><!--Arbortext, Inc., 1988-2019, v.4002--><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
    <channel>
        <title>NEJM This Week</title>
        <link>http://www.nejm.org/multimedia/audiosummary</link>
        <language>en-US</language>
        <copyright>Copyright 2026 Massachusetts Medical Society</copyright>
        <itunes:subtitle>Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clin</itunes:subtitle>
        <itunes:author>NEJM Group</itunes:author>
        <itunes:summary>Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.</itunes:summary>
        <description>Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.</description>
        <itunes:type>episodic</itunes:type>
        <itunes:owner>
            <itunes:name>NEJM Group</itunes:name>
            <itunes:email>audio@nejm.org</itunes:email>
        </itunes:owner>
        <image>
            <title>NEJM This Week</title>
            <url>http://podcast.nejm.org/_images/Googl_gadgt_as.gif</url>
            <link>http://www.nejm.org/multimedia/audiosummary</link>
        </image>
        <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
        <itunes:category text="Health &amp; Fitness">
            <itunes:category text="Medicine"/>
        </itunes:category>
        <lastBuildDate>Wed, 22 Apr 2026 14:00:00 -0400</lastBuildDate>
        <ttl>60</ttl>
        <itunes:explicit>no</itunes:explicit>
        <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — April 23, 2026</itunes:title>
            <itunes:episode>16</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — April 23, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>This week, we explore new strategies for blood-pressure control after intracerebral hemorrhage, Covid-19 treatment in higher-risk patients, hormonal therapy for prostate cancer, and anesthesia for tracheal intubation. We review spinal epidural abscess and follow a case of progressive weakness and liver lesions. We examine advances in tRNA research, and Perspectives discuss the use AI in prescribing, pediatric drug research, the impact of pharmaceutical mergers, and the goals of care. Supplement to the New England Journal of Medicine, Vol. 394, No. 16.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/16</link>
            <guid>http://www.nejm.org/toc/nejm/394/16</guid>
            <description><![CDATA[This week, we explore new strategies for blood-pressure control after intracerebral hemorrhage, Covid-19 treatment in higher-risk patients, hormonal therapy for prostate cancer, and anesthesia for tracheal intubation. We review spinal epidural abscess and follow a case of progressive weakness and liver lesions. We examine advances in tRNA research, and Perspectives discuss the use AI in prescribing, pediatric drug research, the impact of pharmaceutical mergers, and the goals of care.]]></description>
            <pubDate>Wed, 22 Apr 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="14626053" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260423.mp3"/>
            <itunes:duration>23:35</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
        <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — April 16, 2026</itunes:title>
            <itunes:episode>15</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — April 16, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/15</link>
            <guid>http://www.nejm.org/toc/nejm/394/15</guid>
            <description><![CDATA[This week, we present new research on stroke prevention, Kawasaki disease, ICU infection strategies, and immune thrombocytopenia. We review hormone therapy and thrombotic risk. A case highlights an evolving diagnosis of severe fatigue and sleep disturbance. Perspectives explore nursing workforce policy, the role of nurse scientists in rebuilding trust, and the health consequences of environmental rollbacks.]]></description>
            <pubDate>Wed, 15 Apr 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="13577498" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260416.mp3"/>
            <itunes:duration>21:50</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
        <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — April 9, 2026</itunes:title>
            <itunes:episode>14</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — April 9, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/14</link>
            <guid>http://www.nejm.org/toc/nejm/394/14</guid>
            <description><![CDATA[This week, we present new research on intensive LDL cholesterol targets, team-based strategies to improve blood pressure control, emerging therapies for immune and oncologic diseases, and a next-generation yellow fever vaccine. We review celiac disease and follow a compelling case of post-procedural complications. Perspectives explore health disparities and efforts to strengthen care in vulnerable communities.]]></description>
            <pubDate>Wed, 08 Apr 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="16567211" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260409.mp3"/>
            <itunes:duration>26:49</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
        <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — April 2, 2026</itunes:title>
            <itunes:episode>13</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — April 2, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/13</link>
            <guid>http://www.nejm.org/toc/nejm/394/13</guid>
            <description><![CDATA[This week, we present new research on treatment for muscle-invasive bladder cancer, left atrial appendage closure versus medical therapy for atrial fibrillation, gene-editing approaches for sickle cell disease and β-thalassemia, and the safety of discontinuing beta-blockers after myocardial infarction. We also review GLP-1 receptor agonists and discuss a Clinical Problem-Solving case of a man with progressive confusion. Perspectives explore corporatization; biologic, as opposed to chronologic, aging; and a legal case that could affect mental-health policy. ]]></description>
            <pubDate>Wed, 01 Apr 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="16435554" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260402.mp3"/>
            <itunes:duration>26:36</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
        <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — March 26, 2026</itunes:title>
            <itunes:episode>12</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — March 26, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/12</link>
            <guid>http://www.nejm.org/toc/nejm/394/12</guid>
            <description><![CDATA[This week, we present new clinical trials on immunotherapy for stage III mismatch repair–deficient colon cancer, early surgery for asymptomatic aortic stenosis, an approach to dengue virus suppression, and advances in gene and prime-editing therapies for rare disorders. We also review minipuberty. We follow the case of a 12-year-old girl with altered mental status and persistent hypoglycemia, and we explore Perspectives on corporate influences on health, vaccine communication, antitrust policy, conflicts of interest, and the meaning of the number needed to treat. ]]></description>
            <pubDate>Wed, 25 Mar 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="17109775" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260326.mp3"/>
            <itunes:duration>27:43</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
        <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — March 12, 2026</itunes:title>
            <itunes:episode>11</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — March 12, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/11</link>
            <guid>http://www.nejm.org/toc/nejm/394/11</guid>
            <description><![CDATA[This week, we explore new evidence comparing oral anticoagulants for acute venous thromboembolism, treatment for chemotherapy-induced thrombocytopenia, and early results of gene therapy for inherited deafness. We also examine evolving strategies for chronic lymphocytic leukemia, review the management of polymyalgia rheumatica, and present a case discussion of a woman with chest pain, dyspnea, and syncope. We explore gastric cancer prevention, competency-based billing, the health consequences of immigration enforcement, access to high-cost gene therapies, and we present a Perspective on good compressions.]]></description>
            <pubDate>Wed, 11 Mar 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="16248780" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260312.mp3"/>
            <itunes:duration>26:17</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — March 5, 2026</itunes:title>
            <itunes:episode>10</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — March 5, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/10</link>
            <guid>http://www.nejm.org/toc/nejm/394/10</guid>
            <description><![CDATA[This week, we explore a phase 3 trial of finerenone in type 1 diabetes and chronic kidney disease and guidance on timing of nonculprit-lesion PCI after STEMI. We cover an investigational therapy for Dravet syndrome and neoadjuvant treatment for high-risk intrahepatic cholangiocarcinoma. We review the effects of radiotherapy on normal tissue, a puzzling case of progressive neurologic decline after suspected foodborne illness, and Perspectives on private equity, the AHEAD model, and medical credit cards.]]></description>
            <pubDate>Wed, 04 Mar 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="14221154" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260305.mp3"/>
            <itunes:duration>22:54</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — February 26, 2026</itunes:title>
            <itunes:episode>9</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — February 26, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/9</link>
            <guid>http://www.nejm.org/toc/nejm/394/9</guid>
            <description><![CDATA[This week, we explore a new standard of care for high-risk HER2-positive early breast cancer, long-acting therapy for people with HIV facing adherence challenges, a first-in-class trial of a p53 reactivator, and tecovirimat for mpox. We review group B streptococcal disease and a revealing case of prosthetic joint infection. Perspectives examine the role of folate therapy, Medicare drug-price negotiation, AI in medical education, and incidental findings.]]></description>
            <pubDate>Wed, 25 Feb 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="16668331" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260226.mp3"/>
            <itunes:duration>26:58</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — February 19, 2026</itunes:title>
            <itunes:episode>8</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — February 19, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/8</link>
            <guid>http://www.nejm.org/toc/nejm/394/8</guid>
            <description><![CDATA[This week, we highlight major advances in multiple myeloma, gene therapy for cystinosis, and experimental treatments for myotonic dystrophy. We review long-term outcomes of aortic-valve replacement, strategies for secondary stroke prevention, and a revealing diagnostic case of eosinophilic disease in an older adult. A Sounding Board explores FDA approval standards. Perspectives delve into tobacco cessation, influenza evolution, and the uncertainty patients and clinicians share when facing life-altering diagnoses.]]></description>
            <pubDate>Wed, 18 Feb 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="15657370" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260219.mp3"/>
            <itunes:duration>25:18</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — February 12, 2026</itunes:title>
            <itunes:episode>7</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — February 12, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/7</link>
            <guid>http://www.nejm.org/toc/nejm/394/7</guid>
            <description><![CDATA[This week includes studies on promising new therapies for IgA nephropathy, evolving antithrombotic strategies after coronary stenting, and the inciting antigen in rare vaccine-related clotting syndromes. We review the urgent challenge of mucormycosis and follow the case of a young woman with headaches and hypertension. We discuss human-subjects research. Perspectives examine rural health, data interoperability, drug labels in the courts, and a pediatrician’s dilemma.]]></description>
            <pubDate>Wed, 11 Feb 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="14855934" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260212.mp3"/>
            <itunes:duration>23:58</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — February 5, 2026</itunes:title>
            <itunes:episode>6</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — February 5, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/6</link>
            <guid>http://www.nejm.org/toc/nejm/394/6</guid>
            <description><![CDATA[This week, we look at new evidence on oral cholesterol-lowering therapy, the evolving role of beta-blockers after myocardial infarction, and advances in breast and prostate cancer treatment. We review the inherited risk of coronary disease. We also work through a revealing diagnostic case in a young woman and reflect on science under pressure, corporatized insurance, the reach of FDA law, and what it means to live with life-sustaining technology.]]></description>
            <pubDate>Wed, 04 Feb 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="15673565" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260205.mp3"/>
            <itunes:duration>25:19</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — January 29, 2026</itunes:title>
            <itunes:episode>5</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — January 29, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/5</link>
            <guid>http://www.nejm.org/toc/nejm/394/5</guid>
            <description><![CDATA[This week, we explore new therapies to reduce pancreatitis risk in severe hypertriglyceridemia, advances in breast cancer treatment, and long-term results of gene therapy for hemophilia B. We discuss vision-threatening vascular emergencies, the mental health effects of firearm injury on families, and care for peripheral artery disease. We also follow a revealing diagnostic case in an older woman with respiratory failure. Perspectives reflect on hypertension control, immunization access, chronic disease policy, and on the inherited risk of disease.]]></description>
            <pubDate>Wed, 28 Jan 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="15938186" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260129.mp3"/>
            <itunes:duration>25:46</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — January 22, 2026</itunes:title>
            <itunes:episode>4</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — January 22, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/4</link>
            <guid>http://www.nejm.org/toc/nejm/394/4</guid>
            <description><![CDATA[In this episode, we explore evolving evidence on anticoagulation after atrial fibrillation ablation, long-term outcomes with immunotherapy for melanoma, and promising new treatments for hepatitis D and triple-negative breast cancer. We review advances in physiologic pacing for heart failure and work through a challenging case involving fever, rash, and neurologic symptoms. An article considers fairness for late-career physicians, and Perspectives discuss misconceptions about autism, access to contraception, and the financial pressures shaping health care.]]></description>
            <pubDate>Wed, 21 Jan 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="16897924" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260122.mp3"/>
            <itunes:duration>27:22</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — January 15, 2026</itunes:title>
            <itunes:episode>3</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — January 15, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/3</link>
            <guid>http://www.nejm.org/toc/nejm/394/3</guid>
            <description><![CDATA[This week, we explore new evidence on managing asymptomatic carotid stenosis, restoring vision in advanced macular degeneration, and preventing migraine in children. We discuss innovative cellular therapy for autoimmune disease, review sudden cardiac arrest in athletes, and describe a case of severe systemic infection with vision loss. Perspectives examine global tobacco risks, the future of telehealth payment, Medicare coverage of new technologies, and the things physicians carry.]]></description>
            <pubDate>Wed, 14 Jan 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="14925862" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260115.mp3"/>
            <itunes:duration>24:05</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — January 8, 2026</itunes:title>
            <itunes:episode>2</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — January 8, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/2</link>
            <guid>http://www.nejm.org/toc/nejm/394/2</guid>
            <description><![CDATA[This week, we explore new options in cardiovascular prevention, fish-oil supplementation in dialysis patients, RSV vaccination, and cutting-edge cellular therapy for leukemia. We discuss advances in lung cancer treatment, approaches to functional dyspepsia, and a complex case of severe infection after travel. Perspectives examine access to and cost of weight-loss drugs, the promise and risks of AI in clinical care, and what it means to care for others while carrying personal loss.]]></description>
            <pubDate>Wed, 07 Jan 2026 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="15580568" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260108.mp3"/>
            <itunes:duration>25:10</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — January 1, 2026</itunes:title>
            <itunes:episode>1</itunes:episode>
            <itunes:season>41</itunes:season>
            <title>NEJM This Week — January 1, 2026</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/394/1</link>
            <guid>http://www.nejm.org/toc/nejm/394/1</guid>
            <description><![CDATA[This week, we share advances in treatment for EGFR-mutated lung cancer, a brain-penetrant enzyme therapy for a rare pediatric disorder, and dual targeting of extramedullary myeloma. We review cardiogenic shock, work through a challenging diagnostic puzzle in a young woman with recurrent illness, and explore Perspectives on corporatized care, vaccine policy, AI in medicine, and where clinicians carry grief.]]></description>
            <pubDate>Wed, 31 Dec 2025 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="15821940" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo260101.mp3"/>
            <itunes:duration>25:34</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — December 18, 2025</itunes:title>
            <itunes:episode>24</itunes:episode>
            <itunes:season>40</itunes:season>
            <title>NEJM This Week — December 18, 2025</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/393/24</link>
            <guid>http://www.nejm.org/toc/nejm/393/24</guid>
            <description><![CDATA[This week, we look at ctDNA-guided immunotherapy for bladder cancer, cardiovascular outcomes with tirzepatide, and evidence that one HPV vaccine dose may be enough. We explore high-dose rifampin for tuberculous meningitis, review measles amid rising outbreaks, and follow a challenging case of gastrointestinal bleeding. Essays examine how clinicians navigate post-Dobbs care, tobacco harm among people with mental illness, congenital syphilis, and sustaining medical research.]]></description>
            <pubDate>Wed, 17 Dec 2025 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="14570155" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo251218.mp3"/>
            <itunes:duration>23:29</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
            <item>
                    <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — December 11, 2025</itunes:title>
            <itunes:episode>23</itunes:episode>
            <itunes:season>40</itunes:season>
            <title>NEJM This Week — December 11, 2025</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/393/23</link>
            <guid>http://www.nejm.org/toc/nejm/393/23</guid>
            <description><![CDATA[This week, we look at new studies on high-dose influenza vaccines for older adults, antiplatelet therapy after coronary surgery, and HER2-targeted immunotherapy for advanced bladder cancer. We review complex regional pain syndrome and a pediatric case of fever and rash. We also explore FDA innovation and safety, aspirin’s role in metastasis prevention, the meaning of “the good doctor,” smallpox in the Revolution, and how AI may reshape medical science.]]></description>
            <pubDate>Wed, 10 Dec 2025 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="16847249" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo251211.mp3"/>
            <itunes:duration>27:17</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — December 4, 2025</itunes:title>
            <itunes:episode>22</itunes:episode>
            <itunes:season>40</itunes:season>
            <title>NEJM This Week — December 4, 2025</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/393/22</link>
            <guid>http://www.nejm.org/toc/nejm/393/22</guid>
            <description><![CDATA[This week, we look at new trials on glucocorticoids for pneumonia in Africa, shunting for normal-pressure hydrocephalus, and pegcetacoplan for two rare kidney diseases. We review updated vaccine evidence for Covid-19, RSV, and influenza, and present a case of respiratory decline and muscle weakness. Perspectives explore health care incentives, U.S. global health strategy, and bringing AI-enabled care to rural America.]]></description>
            <pubDate>Wed, 03 Dec 2025 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="13340832" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo251204.mp3"/>
            <itunes:duration>21:26</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — November 27, 2025</itunes:title>
            <itunes:episode>21</itunes:episode>
            <itunes:season>40</itunes:season>
            <title>NEJM This Week — November 27, 2025</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/393/21</link>
            <guid>http://www.nejm.org/toc/nejm/393/21</guid>
            <description><![CDATA[This week, we look at new studies on early aspirin discontinuation after myocardial infarction, an antiviral pill for dengue prevention, and CRISPR-based gene editing for lipid disorders. We review bedside clinical teaching and present a complex case of seizures and visual disturbances. Perspectives explore antidepressant safety in pregnancy, restoring trust in public health, academic medical centers’ venture investments, and a young physician’s wrinkled white coat.]]></description>
            <pubDate>Wed, 26 Nov 2025 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="13998335" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo251127.mp3"/>
            <itunes:duration>22:32</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — November 20, 2025</itunes:title>
            <itunes:episode>20</itunes:episode>
            <itunes:season>40</itunes:season>
            <title>NEJM This Week — November 20, 2025</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/393/20</link>
            <guid>http://www.nejm.org/toc/nejm/393/20</guid>
            <description><![CDATA[This week, we look at new research on potassium optimization in patients with defibrillators, reducing antihypertensive therapy in nursing homes, an mRNA influenza vaccine, and belzutifan for rare neuroendocrine tumors. We review long QT syndrome and present a case of abnormal behavior and seizures in a young man. We also explore perspectives on primary care reform, tobacco cessation in HIV and tuberculosis care, corporate control in health care, and the simple power of compassion with ice cream.]]></description>
            <pubDate>Wed, 19 Nov 2025 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="14809698" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo251120.mp3"/>
            <itunes:duration>23:53</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
                <item>
            <itunes:episodeType>full</itunes:episodeType>
            <itunes:title>NEJM This Week — November 13, 2025</itunes:title>
            <itunes:episode>19</itunes:episode>
            <itunes:season>40</itunes:season>
            <title>NEJM This Week — November 13, 2025</title>
            <itunes:author>The New England Journal of Medicine</itunes:author>
            <itunes:subtitle>Podcast of news and medicine from the NEJM.</itunes:subtitle>
            <itunes:summary>We discuss the latest in medical research and ideas.</itunes:summary>
            <link>http://www.nejm.org/toc/nejm/393/19</link>
            <guid>http://www.nejm.org/toc/nejm/393/19</guid>
            <description><![CDATA[In this episode, we look at new trials on deferring arterial catheterization in shock, beta-blocker use after myocardial infarction, and a treatment for triple-negative breast cancer. We review acromegaly. A case describes a man with dyspnea, edema, and pacemaker lead displacement. We explore perspectives on the burdens of primary care, the erosion of harm reduction, child health policy, and the meaning of hospice.]]></description>
            <pubDate>Wed, 12 Nov 2025 10:30:00 -0400</pubDate>
            <itunes:image href="http://podcast.nejm.org/_images/nejm_audio_summaries.jpg"/>
            <enclosure length="15190563" type="audio/mpeg" url="http://podcast.nejm.org/summaries/NEJMdo251113.mp3"/>
            <itunes:duration>24:31</itunes:duration>
            <itunes:keywords>medicine, news, medical, doctor, doctors, patients, physician, primary care, clinical practice, hospital, hospitalist, NEJM, New England Journal of Medicine, medical journal, medicine news, medical research, science and medicine</itunes:keywords>
        <itunes:explicit/></item>
    </channel>
</rss>